Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients

• Status: Completed
• Trial end date: 2016-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a prospective, randomized controlled trial to determine if using FloTrac/EV1000 system in neurosurgical patients undergoing craniotomies for aneurysm repair or tumor resection complicated by cerebral edema, or complex spinal surgery including multi-level scoliosis correction, is a more effective way of monitoring fluid.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: NYU Langone Health
• Treatments: Epinephrine; Oxymetazoline; Phenylephrine; Synephrine

Criteria

Inclusion Criteria:

• Neurosurgical patients with concerns for decreased intracranial compliance;

• Orthopedic spine patients;

• Patients scheduled to undergo neurosurgical interventions that include any of the following will be eligible: intracranial aneurysm repair; or, major spine surgery.

Exclusion Criteria:

• Patients with permanent cardiac arrhythmias;

• Patients with severe aortic regurgitation;

• Patients with intra-aortic balloon pump (IABP);

• Patients undergoing emergency surgery; and,

• Women who are pregnant and/or nursing will be excluded.